Duplex-guided thrombin injection for the treatment of iatrogenic pseudoaneurysms.
This study compares duplex-guided thrombin injection (DGTI) with duplex-guided compression (DGC) for the treatment of iatrogenic pseudoaneurysms. A nonrandomized prospective study, approved by the institutional review board, was performed to evaluate the success rate in DGTI versus DGC (with the use of historical data) in patients who arrive at the vascular surgery service for the treatment of iatrogenic pseudoaneurysm as identified by ultrasound examination. DGTI has been shown to have major advantages over DGC, such as improved patient and operator acceptance, shorter pseudoaneurysm thrombosis times, broader patient applications, and higher success rate.
Greene
Kathleen
K
Connecticut Vascular Institute, Hartford 06106, USA.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017541:Aneurysm, False / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing; D001458:Bandages / Q000592:standards*; D005260:Female; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013917:Thrombin / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D018616:Ultrasonography, Doppler, Duplex / Q000009:adverse effects / Q000379:methods* / Q000451:nursing; D018084:Ultrasonography, Interventional / Q000009:adverse effects / Q000379:methods* / Q000451:nursing
D006490:Hemostatics; D013917:Thrombin